期刊文献+

^(18)F-FDG PET-CT在肺癌诊断中的应用 被引量:1

下载PDF
导出
出处 《现代临床医学》 2010年第4期243-245,共3页 Journal of Modern Clinical Medicine
  • 相关文献

参考文献18

  • 1He J,Gu D,Wu X,et al.Major causes of death amongmen and women in China[J].N Engl J Med,2005,353(11):1124-l134.
  • 2宋吉清,张成琪.PET-CT对肺癌的临床应用进展[J].医学影像学杂志,2005,15(1):66-69. 被引量:9
  • 3Cherry SR.The 2006 Henry N.Wagner Lecture:Of mice and men(and positrons)-advances in PET imaging technology[J].J Nucl Med,2006,47(11):1735-1745.
  • 4Halpern BS,Schiepers C,Weber WA,et al.Presurgical staging of non-small cell 1ung cancer:positron emis-sion tomography,integrated positron emission tomography/CT,and software image fusion[J].Chest,2005,128(4):2289-2297.
  • 5Dewan NA,Reeb SD,Gupta NC,et al.PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions.A comparative risk-benefit analysis[J].Chest,1995,108(2):441-446.
  • 6DeLeyn P,Stroobants S,DeWever W,et al.Prospective conparativestudy of integrated positron emission tomography-computed tomography scan cmnpared with remed;astinoscopy in the assessmentof residual mediastinal lymph node disease after induction chemotherapy for mediastinoscop-proven stageⅢ A-N2 non-small-cell lung cancer:a Leuven Lung Cancer Group Study[J].J Clin Oncol,2006,24(21):3333-3339.
  • 7Duhaylongsod FG,Lowe VJ,Patz EF,et al.Detectionof primary and recurrent lung cancer by means of 18FDG-PET[J].J Thorac Cardiovasc Surg,1995,110(1):130-139.
  • 8Demura Y,Tsuchida T,Ighizki T,et al.18 FDG for differention between benign and malignant lesionsin the thorax[J].J Nucl Med,2003.44(4):540-548.
  • 9Frank C,Daniel J,Lynn T.The New Lung Cancer Staging System[J].Chest,2009,136:260-271.
  • 10Kanishi J,Yamazaki K,TsukamotoE,et al.Mediastinal lymph.node Staging by FDG-PET in patients with non-small cell lung cancerI analysis of false-positive FDG-PET findings[J].Respiration,2003,70(5):500-506.

二级参考文献8

  • 1Ogawa Mikako.^18F-FDG accumulation in atherosclerotic plaques:immunohistochemical and PET imaging study[J]. J Nucl Med,2004,45:1245-1250.
  • 2Vesselle H.In vivo alidation of 3' deoxy-3'-[^18F] fluorothymivdine ([^18F]FET) as a proliferation imaging tracer in human:correlation of [^18F]FET uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors[J].Clinical Cancer Research,2002,8:3315-3323.
  • 3Cerfolio RJ,Ojha B,Bryant AS,et al.The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer[J]. Ann Thorac Surg,2004,78:1017-1023.
  • 4Antoch G, Stattaus J, Nemat AT,et al.Non-small cell lung cancer:dual-modality PET/CT in preoperative staging[J].Radiology,2003,229:526-533.
  • 5Lardinosis D, Weder W, Hany TF,et al.Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography[J]. N Engl J Med,2003,19:348:2500-2507.
  • 6Bradley J, Thorstad WL, Mutic S,et al.Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer[J]. Int J Radiat Oncol Biol Phys,2004,59:78-86.
  • 7Erdi YE, Rosenzweig K, Erdi AK,et al.Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography(PET)[J].Radiother Oncol,2002,62:51-60.
  • 8高硕.功能分子影像设备CT-PET及其临床应用[J].天津医药,2003,31(1):61-64. 被引量:11

共引文献8

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部